Rationale: Vitamin D has immunomodulatory and anti-inflammatory effects which may be modified by cigarette smoke and affect lung function.
Methods: 626 men from the Normative Aging Study had 25-hydroxyvitamin D levels measured at 3 different times between 1984 and 2003 with concurrent spirometry. Vitamin D deficiency was defined as serum level ≤ 20ng/ml. Statistical analysis was performed using multivariable linear regression and mixed effects models.
Measurements and Main Results: In the overall cohort, there was no significant effect of vitamin D deficiency on lung function nor on lung function decline. In both cross-sectional and longitudinal multivariable models there was effect modification by vitamin D status on the association between smoking and lung function. Cross-sectional analysis revealed lower lung function in current smokers with vitamin D deficiency (FEV1, FVC, and FEV1/FVC, p≤ 0.0002) and longitudinal analysis showed more rapid rates of decline in FEV1 (p=0.023) per pack-year of smoking in subjects with vitamin D deficiency as compared to subjects who were vitamin D sufficient. 
